With the Reserve Bank of Australia expected to take rates even lower in the coming months, if I had $5,000 in a savings account gaining only a modicum of interest, I would consider putting it to work in the share market instead.
Three top ASX 200 shares that I think would be great options for these funds are listed below. Here’s why I like them:
Cochlear Limited (ASX: COH)
Cochlear is one of the world’s leading hearing solutions companies, manufacturing and distributing industry-leading cochlear implantable devices for the hearing impaired globally. Thanks to the quality of its products, high levels of investment in research and development, and increasing demand, Cochlear has delivered consistently strong earnings growth over the last decade. The good news for the company and its shareholders is that the world is getting older and the number of people aged 65 is expected to increase significantly over the next three decades. I expect this to lead to increasing demand and strong sales growth for many years to come.
REA Group Limited (ASX: REA)
With recent data revealing that the Australian housing market could be close to bottoming, many believe a rebound in house prices could be coming in 2020. This would be a big lift for REA Group and its key realestate.com.au property listings website, as it could lead to a notable increase in property listings and ultimately an acceleration in the company’s profit growth. In light of this, I think now would be a good time to consider picking up shares with a long-term view.
Xero Limited (ASX: XRO)
Another good option for that $5,000 investment could be this cloud-based business and accounting software provider. Thanks to a combination of growth in subscribers and average revenue per user, Xero has been growing its top line at an incredible rate in recent years. Given its massive global market opportunity, high quality product, and strong pricing power, I believe it is well-placed to continue this trend for a long time to come. This could arguably make it one of the best buy and hold options on the local market.
And here are two exciting tech shares that could also be great options for that $5,000 right now. Both have been tipped for very big things.
These ASX shares have shot up 204% and even 954%, but we think they’re just getting started
The $700 billion “war on cash” is on… and even The New York Times is calling it “a goldmine of staggering proportions”…
That’s why The Motley Fool has just released a brand-new research report: “Leave Your Wallet at Home: 2 Stocks for the Digital Payments Revolution.” Inside, you’ll find 2 expert-picked ASX shares poised to profit from this sweeping tech revolution.
Heck, stock #1 is already up 204% in just the last two years. While Stock #2 has climbed an eye-watering 954% since 2015 alone…
Yet we’re convinced the sheer biggest returns could be still ahead, with 10X or more potential profits still on the table. Simply click the link below now and we’ll show you how to snap up this timely (and potentially highly profitable) new research for FREE.
Click here to snap up your copy of “Leave Your Wallet at Home: 2 Stocks for the Digital Payments Revolution.”
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia owns shares of Xero. The Motley Fool Australia has recommended Cochlear Ltd. and REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019